Medtronic MDT
NYSE MDT
$93.72 -0.40 (-0.43%)
At close: Aug 20, 2026 · 11:13 AM UTC

Medtronic (MDT) Total Non-Current Liabilities (2014 - 2026)

Medtronic (MDT) posted Total Non-Current Liabilities of $41.4 billion for Q2 2026, up 2.28% sequentially from $40.5 billion in Q1 2026, and down 0.51% YoY from $41.7 billion in Q2 2025.

Medtronic (MDT) Total Non-Current Liabilities (2014 - 2026) Analysis & Trends

Medtronic has reported Total Non-Current Liabilities for 13 years, with the latest figure at $41.4 billion in Q2 2026.

  • Quarterly Total Non-Current Liabilities fell 0.51% year-over-year to $41.4 billion in Q2 2026, while the trailing twelve-month figure through Apr 2026 was $41.4 billion (down 0.51% YoY) and the FY2026 annual result came in at $41.4 billion, down 0.51% from the prior year.
  • Total Non-Current Liabilities climbed to $41.4 billion in Q2 2026 per MDT's latest filing, from $40.5 billion in the prior quarter.
  • Over five years, Total Non-Current Liabilities peaked at $41.7 billion in Q2 2025 and troughed at $36.2 billion in Q2 2022.
  • A 5-year average of $39.0 billion and a median of $39.3 billion in 2024 frame the typical range for Total Non-Current Liabilities.
  • The sharpest annual moves came in 2022 and 2025: Total Non-Current Liabilities fell 14.54% in 2022, then advanced 9.06% in 2025.
  • Over 5 years, Total Non-Current Liabilities stood at $40.8 billion in 2022, then slipped by 10.22% to $36.7 billion in 2023, then gained by 8.53% to $39.8 billion in 2024, then increased by 2.91% to $41.0 billion in 2025, then gained by 1.2% to $41.4 billion in 2026.
  • According to Business Quant data, Total Non-Current Liabilities over the past three periods registered $41.4 billion, $40.5 billion, and $41.0 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Abbott Laboratories 200.20 Bn 194.60 Bn 7.27 Bn -
2 Stryker 129.69 Bn 126.21 Bn 4.50 Bn 21.28 Bn
3 Medtronic 120.14 Bn 110.92 Bn 6.41 Bn 40.90 Bn
4 Boston Scientific 74.16 Bn 73.62 Bn 3.85 Bn 42.74 Bn
5 Edwards Lifesciences 52.68 Bn 48.43 Bn 1.35 Bn 2.57 Bn
6 Dexcom 34.57 Bn 32.62 Bn 830.00 Mn 3.68 Bn
7 GE HealthCare Technologies 34.09 Bn 31.98 Bn 2.18 Bn 23.89 Bn
8 Koninklijke Philips 26.49 Bn 23.17 Bn 4.55 Bn 9.07 Bn
9 Steris 23.19 Bn 22.70 Bn 684.20 Mn 3.44 Bn
10 Zimmer Biomet Holdings 19.36 Bn 18.95 Bn 1.54 Bn 9.53 Bn

Historic Data

Download Data
DateValue
Apr 24, 2026 41.44 Bn
Jan 23, 2026 40.52 Bn
Oct 24, 2025 40.95 Bn
Jul 25, 2025 41.03 Bn
Apr 25, 2025 41.66 Bn
Jan 24, 2025 38.87 Bn
Oct 25, 2024 39.79 Bn
Jul 26, 2024 39.67 Bn
Apr 26, 2024 38.20 Bn
Jan 26, 2024 37.43 Bn
Oct 27, 2023 36.66 Bn
Jul 28, 2023 37.70 Bn
Apr 28, 2023 36.92 Bn
Jan 27, 2023 40.21 Bn
Oct 28, 2022 40.84 Bn
Jul 29, 2022 36.88 Bn
Apr 29, 2022 36.17 Bn
Jan 28, 2022 37.67 Bn
Oct 29, 2021 39.33 Bn
Jul 30, 2021 39.84 Bn